Trial Profile
A trial of Vedolizumab for the Treatment of Patients with Inflammatory Bowel Disease.
Status:
Not stated
Phase of Trial:
Phase IV
Latest Information Update: 25 Feb 2016
Price :
$35
*
At a glance
- Drugs Vedolizumab (Primary)
- Indications Inflammatory bowel diseases
- Focus Therapeutic Use
- 25 Feb 2016 New trial record